Abstract
In summary, the results of rigorous and creative experiments performed by these investigators confirm the discovery of a novel reductase with VKOR activity. In vivo, VKOR likely functions in conjunction with other proteins to form a complex in the endoplasmic reticulum. Knowledge of the new gene should help in understanding the mechanism of γ-carboxylation of clotting factors and other proteins and may aid in the development of novel drugs. © 2004 Nature Publishing Group All rights reserved.
Cite
CITATION STYLE
Gage, B. F., & Eby, C. S. (2004). The genetics of vitamin K antagonists. Pharmacogenomics Journal. https://doi.org/10.1038/sj.tpj.6500258
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.